Skip to content
About LineaRx
Leadership Team
Investor Info
LinearDNA Platform
Biotherapeutic Applications
News
Resources
Let’s Connect
About
About LineaRx
Leadership Team
Investor Info
Platform
Applications
News
Resources
Let’s Connect
LineaRx to Announce DNA Vaccine Preclinical Data and Efficacy of In-Licensed CAR T Therapy
December 4, 2018
Read More
email
LineaRx Licenses CAR T Drug Candidate, Initiates Pre-Clinical Development of Non-viral, Plasmid-free CAR T Manufacturing Platform
October 16, 2018
Read More
email
APDN Presenting Linear DNA for Gene Therapy at Boston Immuno-Oncology Summit
August 27, 2018
Read More
email
Recent Press Releases
Applied DNA Enters into Agreement with Alphazyme for Scale-Up Manufacturing of its Proprietary Linea™ RNAP, Progresses Towards GMP Linea™ IVT Production Start
Applied DNA to Showcase Linea™ DNA and Linea™ IVT Platforms
Applied DNA Announces Joint Development Agreement to Integrate Linea™ IVT Platform into CDMO Kudo Biotechnology’s mRNA Manufacturing Workflow
APDN Announces Receipt of Linea™ DNA Follow-On Order for Cancer Diagnostic Application
Applied DNA Extends Application of Linea™ IVT Platform to saRNA (self-amplifying mRNA)
Applied DNA Ships First saRNA (self-amplifying mRNA) IVT Template Generated by Linea™ DNA Platform
APDN Partners with Cornell University College of Veterinary Medicine to Accelerate Development of Veterinary Vaccine Platform Targeting Diseases that Impact High-Value Animals
APDN Advances Commercialization of Linea™ IVT Platform, Appoints Beverly Wolgast as Executive Director of Quality and cGMP Programs
LineaRx to Participate in Upcoming mRNA Industry Conferences
APDN Acquires RNA Polymerase Developer Spindle Biotech, Launches LineaIVT™ Platform to Substantially Improve mRNA Manufacturing and Broaden Market Reach
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.
Ok
